# ACUTE RESPIRATORY DISTRESS SYNDROME

## Berlin 定義 (_JAMA_ 2012;307:2526)

• Acute onset within 1 week of 臨床insult or worsening respiratory status

• Bilateral infiltrates withoutut alternative explanation (eg, effusion, atelectasis, nodules)

• Edema not fully explained by fluid overload or congestive heart failure

• Hypoxemia: PaO2/FiO2 determined with 5 cm H2O of PEEP

PaO2/FiO2 200–300 = mild ARDS (may be on NPPV), 100–200 = mod, <100 = severe

## 病生理 (_Lancet_ 2016;388:2416)

• ↑ intrapulmonary shunt → hypoxemia (∴ Rx with PEEP to prevent derecruitment)

• ↑ increased dead space fraction (see Appendix), predicts ↑ mort (_NEJM_ 2002;346:1281)

• ↓ compliance: VT/(Pplat – PEEP) <50 mL/cm H2O

## Pathology

• Diffuse alveolar damage (DAD) seen in 40% of autopsies (_AJRCCM_ 2013;187:761)

• If no clear inciting event and ILD considered as alt dx, consider bx (_Chest_ 2015;148:1073)

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>原因</b></p></td></tr><tr><td><p>Direct Injury</p></td><td><p>Indirect Injury</p></td></tr><tr><td><p><span>•</span> Pneumonia (~40%) • Inhalation injury</p><p><span>•</span> Aspiration (~15%)&nbsp;&nbsp;&nbsp;• Lung contusion</p><p><span>•</span> Near drowning</p></td><td><p><span>•</span> Sepsis (~25%)&nbsp;&nbsp;• Pancreatitis</p><p><span>•</span> Shock<span></span>• Trauma/multiple fractures</p><p><span>•</span> DIC<span></span>&nbsp;&nbsp;&nbsp;&nbsp;• Transfusion (TRALI)</p></td></tr></tbody></table>

## 治療 (_NEJM_ 2017;377:562; _ARJCCM_ 2017;195:1253; _JAMA_ 2018;319:698)

• Goal is to maintain gas exchange, sustain life, & avoid ventilator-induced lung injury (VILI)

<table><colgroup><col> <col></colgroup><tbody><tr><td><p><b>Mechanisms of VILI</b></p></td><td><p>Ventilator Strategies (see <a href="http://ardsnet.org/">ARDSnet.org</a>)</p></td></tr><tr><td><p><b>Barotrauma/volutrauma:</b> alveolar dist → mech damage</p></td><td><p><b>V<sub>T</sub></b> ≤<b>6 mL/kg, P<sub>plat</sub></b> ≤<b>30 cm H<sub>2</sub>O</b>, tolerate ↑ P<sub>a</sub>CO<sub>2</sub> (but keep pH &gt;7.2), ↓ mortality (<span><i>NEJM</i> 2000;342:1301</span>)</p></td></tr><tr><td><p><b>Biotrauma</b> → SIRS</p></td><td><p>Low V<sub>T</sub>, open lung strategy with high PEEP</p></td></tr><tr><td><p><b>Atelectrauma:</b> repetitive alveoli recruit &amp; decruit</p></td><td><p><b>Titrate PEEP to prevent tidal alveolar collapse</b></p><p>See below for options</p></td></tr><tr><td><p><b>Hyperoxia:</b> ? injury; worsened V/Q matching</p></td><td><p>↑ <b>PEEP</b> rather than F<sub>i</sub>O<sub>2</sub> (keep &lt;0.60)</p><p>O<sub>2</sub>-induced injury only theoretical in humans</p></td></tr></tbody></table>

## The 6 Ps

• **PEEP** (see below)

• **Proning:** if PaO2/FiO2 <150, prone positioning ≥16 h ↓ mort ~50% (_NEJM_ 2013;368:2159)

• **Paralysis:** no benefit routinely (_NEJM_ 2019;380:1997); consider if Pt-vent dyssynchrony

• **Peeing (fluid balance):** target CVP 4–6 cm H2O (if nonoliguric & normotensive) → ↑ vent/ICU-free days, but no Δ mortality (_NEJM_ 2006;354:2564); PA catheter unproven (_NEJM_ 2006;354:2213); consider BNP >200 to trigger diuresis (UOP goal 4.5–9 mL/kg/h × 3 h)

• **Pulm vasodilators:** inhaled NO or prostacyclins ↑ PaO2/FiO2; no ↓ mort or vent-free days (_BMJ_ 2007;334:779)

• **Perfusion (V-V ECMO):** may be useful if refractory (_NEJM_ 2011;365:1905 & 2018;378:1965)

## PEEP titration methods (best method unclear)

• No benefit at given VT if titrated to PaO2 alone (_NEJM_ 2004;351:327; _JAMA_ 2008;299:637)

• Best PEEP trial: incremental PEEP titration using compliance, O2, hemodynamics

If able to ↑ PEEP without ↑ Pplat, suggests “recruitability”

∴↑ PEEP if → ↑ SaO2 (target ≥88–90%) & Pplat ≤30 cm H2O → ↓ time on vent, better lung mechanics (_JAMA_ 2008;299:646), ? ↓ mortality (_JAMA_ 2010;303:865)

• ARDSnet “high” PEEP table for optimal FiO2/PEEP combo for goal SaO2 ([ARDSnet.org](http://ardsnet.org/))

• Recruitment maneuvers: stepwise preferred over sustained inflation, evidence insufficient to recommend routine use (_Resp Care_ 2015;60:1688); recruitment maneuvers at high pressures ? ↑ mortality (_JAMA_ 2017;318:1335)

• Esophageal balloon: used to estimate pleural pressure and thereby estimate trans-pulmonary pressure (ie, true airway distending pressure). Adjusting PEEP according to esoph pressure to maintain optimal transpulm. pressure does not Δ ventilator-free days or mortality, although does ↓ need for advanced rescue Rx (see above) (_JAMA_ 2019;321:846).

• Driving pressure (ΔP = Pplateau–PEEP): ↓ ΔP a/w ↑ survival; target <15 (_NEJM_ 2015;372:747)

## Prognosis (_JAMA_ 2016;315:788)

• Mortality ~40% overall in 臨床trials; 9–15% resp. causes, 85–91% extrapulm (MODS)

• Survivors: 肺功能 ~normal, ↓ DLCO, muscle wasting, weakness persists (_NEJM_ 2003;348:683), ↓ exercise tolerance, ↓ 生活品質, ↑ psych morbidity (_NEJM_ 2011;364:1293); 44% of previously employed 病人 jobless at 12 mos (_AJRCCM_ 2017;196:1012)
